These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


136 related items for PubMed ID: 4332626

  • 1. Hypertension of renal origin: evidence for two different mechanisms.
    Brunner HR, Kirshman JD, Sealey JE, Laragh JH.
    Science; 1971 Dec 24; 174(4016):1344-6. PubMed ID: 4332626
    [Abstract] [Full Text] [Related]

  • 2. Use of angiotensin II antagonists in experimental hypertension.
    Bumpus FM, Smeby RR, Sweet C, Ferrario CM, Khosla MC.
    Circ Res; 1973 May 05; 32():Suppl 1:150-8. PubMed ID: 4351356
    [No Abstract] [Full Text] [Related]

  • 3. Role of angiotensin II in experimental renal hypertension in the rabbit.
    Johnson JA, Davis JO, Braverman B.
    Am J Physiol; 1975 Jan 05; 228(1):11-6. PubMed ID: 1146999
    [Abstract] [Full Text] [Related]

  • 4. Editorial: Angiotensin inhibition.
    Chobanian AV.
    N Engl J Med; 1974 Oct 17; 291(16):844-5. PubMed ID: 4371423
    [No Abstract] [Full Text] [Related]

  • 5. Role of the renin-system in normo- and hypertension. Effect of angiotensin-inhibitor (1-sar-8-ala-angiotensin II) on the blood pressure of conscious or anaesthetized normal, nephrectomized and renal hypertensive rats.
    Bing J, Nielsen K.
    Acta Pathol Microbiol Scand A; 1973 May 17; 81(3):254-62. PubMed ID: 4358386
    [No Abstract] [Full Text] [Related]

  • 6. Pressor responsiveness to renin and angiotensin in renal hypertensive rats.
    Aoki K, Masson GM.
    Nephron; 1969 May 17; 6(4):484-97. PubMed ID: 4310884
    [No Abstract] [Full Text] [Related]

  • 7. Studies on the role of angiotensin in experimental renovascular hypertension: an immunologic approach.
    Christlieb AR, Biber TU, Hickler RB.
    J Clin Invest; 1969 Aug 17; 48(8):1506-18. PubMed ID: 4307701
    [Abstract] [Full Text] [Related]

  • 8. Renovascular hypertension in rats immunized with angiotensin II.
    Eide I.
    Circ Res; 1972 Feb 17; 30(2):149-57. PubMed ID: 4334414
    [No Abstract] [Full Text] [Related]

  • 9. Mechanism of renal hypertension.
    Brown JJ, Davies DL, Morton JJ, Robertson JI, Cuesta V, Lever AF, Padfield PL, Trust P.
    Lancet; 1976 Jun 05; 1(7971):1219-21. PubMed ID: 58263
    [Abstract] [Full Text] [Related]

  • 10. Continuous angiotensin II blockade throughout the acute phase of one-kidney hypertension in the dog.
    Watkins BE, Davis JO, Freeman RH, DeForrest JM, Stephens GA.
    Circ Res; 1978 Jun 05; 42(6):813-21. PubMed ID: 657442
    [No Abstract] [Full Text] [Related]

  • 11. Can angiotensin II cause renal hypertension when its plasma concentration is normal?
    Brown JJ, Cuesta V, Davies DL, Lever AF, Morton JJ, Padfield PL, Robertson JI, Trust P, Bianchi G, Schalekamp MA.
    Contrib Nephrol; 1977 Jun 05; 8():57-60. PubMed ID: 891218
    [No Abstract] [Full Text] [Related]

  • 12. Antagonists of angiotensin. Effect on the blood pressure of normal and hypertensive rats.
    Saint-Louis J, Regoli D.
    Rev Can Biol; 1972 Dec 05; 31(4):241-51. PubMed ID: 4350595
    [No Abstract] [Full Text] [Related]

  • 13. Angiotensin-sodium interaction in blood pressure maintenance of renal hypertensive and normotensive rats.
    Gavras H, Brunner HB, Vaughan ED, Laragh JH.
    Science; 1973 Jun 29; 180(4093):1369-71. PubMed ID: 4350930
    [Abstract] [Full Text] [Related]

  • 14. Effect of 12-hour infusions of saralasin or captopril on blood pressure in hypertensive conscious rats. Relationship to plasma renin, duration of hypertension, and effect of unclipping.
    Bing RF, Russell GI, Swales JD, Thurston H.
    J Lab Clin Med; 1981 Aug 29; 98(2):302-10. PubMed ID: 7019368
    [Abstract] [Full Text] [Related]

  • 15. Effect of angiotensin II and an angiotensin II inhibitor on renin secretion in the dog.
    McDonald KM, Taher S, Aisenbrey G, De Torrente A, Schrier RW.
    Am J Physiol; 1975 May 29; 228(5):1562-7. PubMed ID: 1130560
    [Abstract] [Full Text] [Related]

  • 16. On the pathogensis of renovascular hypertension.
    Eide I.
    Scand J Clin Lab Invest; 1973 Mar 29; 31(2):129-32. PubMed ID: 4354731
    [No Abstract] [Full Text] [Related]

  • 17. Pathogenic factors involved in renovascular hypertension. State of the art.
    Bumpus FM, Khosla MC.
    Mayo Clin Proc; 1977 Jul 29; 52(7):417-23. PubMed ID: 327161
    [Abstract] [Full Text] [Related]

  • 18. [Study on the renin-angiotensin-aldosterone system. Evaluation of the dynamics of renal renin and adrenal cortex aldosterone production in the chronic stage of Goldblatt's rats].
    Okano M.
    Jpn Circ J; 1967 Nov 29; 31(11):1773-83. PubMed ID: 4308547
    [No Abstract] [Full Text] [Related]

  • 19. Renin. Its release mechanisms and its vasoconstrictive effects in renovascular hypertension.
    Eide I.
    J Oslo City Hosp; 1975 Mar 29; 25(3):37-54. PubMed ID: 1127493
    [No Abstract] [Full Text] [Related]

  • 20. Accelerated induction to two-kidney hypertension in rats and renin-angiotensin sensitivity.
    Skulan TW, Brousseau AC, Leonard KA.
    Circ Res; 1974 Nov 29; 35(5):734-41. PubMed ID: 4371192
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.